Biological Effect of Vitamin D in Patients With Urothelial Carcinoma

PHASE4CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 11, 2020

Primary Completion Date

November 22, 2021

Study Completion Date

November 22, 2021

Conditions
Urothelial Carcinoma
Interventions
DRUG

Vitamin D

First dose of 10.000 IU Vitamin D at baseline visit for all patients; stratification of treatment (10.000 or 50.000 IU Vitamin D) depending base 25(OH)Vitamin D levels. Treatment weekly during 4 weeks before scheduled cystectomy

Trial Locations (1)

08916

Hospital Germans Trias i Pujol, Badalona

All Listed Sponsors
collaborator

Spanish Clinical Research Network - SCReN

NETWORK

collaborator

Centro Nacional de Investigaciones Oncologicas CARLOS III

OTHER

collaborator

Fundació Institut Germans Trias i Pujol

OTHER

lead

Germans Trias i Pujol Hospital

OTHER

NCT04197089 - Biological Effect of Vitamin D in Patients With Urothelial Carcinoma | Biotech Hunter | Biotech Hunter